The Contraceptive Choice Project
|ClinicalTrials.gov Identifier: NCT01986439|
Recruitment Status : Unknown
Verified April 2015 by Jeffrey Peipert, Washington University School of Medicine.
Recruitment status was: Active, not recruiting
First Posted : November 18, 2013
Last Update Posted : April 14, 2015
|Condition or disease|
|Unintended Pregnancy Teen Births Abortion Contraception|
|Study Type :||Observational|
|Actual Enrollment :||9256 participants|
|Official Title:||The Contraceptive Choice Project|
|Study Start Date :||August 2007|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2016|
- Distribution of contraceptive method chosen [ Time Frame: Baseline ]Distribution of methods (%) chosen at baseline enrollment, by method and stratified by Long-Acting Reversible Contraception (LARC: intrauterine device and implant) and non-LARC (depotmedroxyprogesterone acetate (DMPA), oral contraceptive pill (OCP), vaginal ring, transdermal patch).
- Method Continuation [ Time Frame: 6-month, 12 month, 24-month, and 36-month ]% of women using each method at 6, 12-, 24, and 36 months post-enrollment. Hazard rates via survival analysis comparing LARC and non-LARC methods.
- Method Satisfaction [ Time Frame: 12-month, 24-month, 36-month ]% of women very or somewhat satisfied with method at 12, 24, and 36 months of use. Comparison of all methods and stratified by LARC and non-LARC methods.
- Teen Pregnancy Rates [ Time Frame: 1-year, 2-year, 3-year ]Number of pregnancies per participants 15-19 years of age. We will calculate an annual rate for each year from 2007-2013 and also calculate a rate for the cohort followed for 1 year, 2 years, and 3 years.
- Repeat Abortion Rates [ Time Frame: 1-year, 2-year, 3-year ]Number of abortions among participants 15-44 with a history of abortion. We will calculate an annual rate for each year from 2007-2013 and also calculate a rate for the cohort followed for 1 year, 2 years, and 3 years.
- Sexually transmitted infection rates [ Time Frame: Baseline and 12-months ]Baseline prevalence rates (number positive divided by number tested) for chlamydia, gonorrhea, and trichomonas. 1-year incidence rates for the same infections among those who tested at 1-year.
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01986439
|United States, Missouri|
|Washington University in St. Louis School of Medicine|
|St. Louis, Missouri, United States, 63110|
|Principal Investigator:||Jeffrey F Peipert, MD PhD||Washington University School of Medicine|